• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种远亲逆转录病毒包膜蛋白增强 HIV-1 中和抗体反应。

Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.

机构信息

Science for Life Laboratory, Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska University Hospital Huddinge, Karolinska Institutet, S-14186 Stockholm, Sweden;

The Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom;

出版信息

J Immunol. 2014 Jun 15;192(12):5802-12. doi: 10.4049/jimmunol.1301898. Epub 2014 May 14.

DOI:10.4049/jimmunol.1301898
PMID:24829409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4112278/
Abstract

Our knowledge of the binding sites for neutralizing Abs (NAb) that recognize a broad range of HIV-1 strains (bNAb) has substantially increased in recent years. However, gaps remain in our understanding of how to focus B cell responses to vulnerable conserved sites within the HIV-1 envelope glycoprotein (Env). In this article, we report an immunization strategy composed of a trivalent HIV-1 (clade B envs) DNA prime, followed by a SIVmac239 gp140 Env protein boost that aimed to focus the immune response to structurally conserved parts of the HIV-1 and simian immunodeficiency virus (SIV) Envs. Heterologous NAb titers, primarily to tier 1 HIV-1 isolates, elicited during the trivalent HIV-1 env prime, were significantly increased by the SIVmac239 gp140 protein boost in rabbits. Epitope mapping of Ab-binding reactivity revealed preferential recognition of the C1, C2, V2, V3, and V5 regions. These results provide a proof of concept that a distally related retroviral SIV Env protein boost can increase pre-existing NAb responses against HIV-1.

摘要

近年来,我们对中和抗体(NAb)识别广泛 HIV-1 株(bNAb)的结合位点的了解有了很大的提高。然而,我们对于如何将 B 细胞反应集中到 HIV-1 包膜糖蛋白(Env)中易受影响的保守位点上,仍然存在理解上的差距。在本文中,我们报告了一种免疫策略,由三价 HIV-1(clade B Env)DNA 初免和 SIVmac239 gp140 Env 蛋白加强免疫组成,旨在将免疫反应集中到 HIV-1 和猿猴免疫缺陷病毒(SIV)Env 的结构保守部分上。在兔子中,三价 HIV-1 env 初免诱导的异源 NAb 滴度,主要针对 1 型 HIV-1 分离株,通过 SIVmac239 gp140 蛋白加强免疫显著增加。Ab 结合反应的表位作图显示了对 C1、C2、V2、V3 和 V5 区域的优先识别。这些结果提供了一个概念验证,即远距离相关的逆转录病毒 SIV Env 蛋白加强免疫可以增加针对 HIV-1 的预先存在的 NAb 反应。

相似文献

1
Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.一种远亲逆转录病毒包膜蛋白增强 HIV-1 中和抗体反应。
J Immunol. 2014 Jun 15;192(12):5802-12. doi: 10.4049/jimmunol.1301898. Epub 2014 May 14.
2
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.人类免疫缺陷病毒 C.1086 包膜 gp140 蛋白增强剂在 DNA/改良安卡拉牛痘病毒疫苗接种后未能增强针对 V1V2 抗体的异源反应和对 C 型猴免疫缺陷病毒攻击的保护。
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.00934-19. Print 2019 Oct 15.
3
Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.两种 HIV-1 亚型的包膜蛋白诱导了不同的表位特异性抗体反应。
Vaccine. 2018 Mar 14;36(12):1627-1636. doi: 10.1016/j.vaccine.2018.01.081. Epub 2018 Feb 9.
4
Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.通过初免-加强免疫在兔体内诱导异源2级HIV-1中和及交叉反应性V1/V2特异性抗体
J Virol. 2016 Sep 12;90(19):8644-60. doi: 10.1128/JVI.00853-16. Print 2016 Oct 1.
5
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.非人灵长类动物免疫接种引发的HIV-1交叉反应性原发性病毒中和抗体反应
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00910-17. Print 2017 Nov 1.
6
DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.使用寡聚猿猴免疫缺陷病毒包膜和Advax δ-菊粉佐剂的DNA初免/蛋白加强疫苗接种在恒河猴中引发强烈的体液免疫反应。
J Gen Virol. 2017 Aug;98(8):2143-2155. doi: 10.1099/jgv.0.000863. Epub 2017 Jul 31.
7
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.采用 DNA、改良安卡拉痘苗病毒和基于蛋白的疫苗进行初免-加强免疫可诱导针对 CAP256 超感染病毒的强效 HIV-1 2 型中和抗体。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02155-18. Print 2019 Apr 15.
8
Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations.HIV-1包膜蛋白胞质尾对腺病毒引发的病毒编码病毒样颗粒免疫的影响。
Vaccine. 2016 Oct 17;34(44):5344-5351. doi: 10.1016/j.vaccine.2016.08.089. Epub 2016 Sep 12.
9
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.C 型 HIV-1 包膜疫苗方案在诱导具有中度广谱中和能力的抗体方面存在差异,可针对遗传多样性的 2 级 HIV-1 包膜变异体。
J Virol. 2019 Mar 21;93(7). doi: 10.1128/JVI.01846-18. Print 2019 Apr 1.
10
Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.

引用本文的文献

1
HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers.HIV-1疫苗。由类天然包膜三聚体诱导产生的HIV-1中和抗体。
Science. 2015 Jul 10;349(6244):aac4223. doi: 10.1126/science.aac4223. Epub 2015 Jun 18.

本文引用的文献

1
Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques.在三种不同动物模型(豚鼠、兔子和食蟹猴)中对HIV-1包膜DNA候选疫苗进行优化。
Vaccines (Basel). 2013 Jul 19;1(3):305-27. doi: 10.3390/vaccines1030305.
2
HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo.HIV-1 Env DNA 疫苗加 EP 递呈的蛋白加强免疫可在体内扩增 B 细胞和 T 细胞应答及中和表型。
PLoS One. 2013 Dec 31;8(12):e84234. doi: 10.1371/journal.pone.0084234. eCollection 2013.
3
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.
疫苗介导的 SIV 和 HIV 保护的免疫和病毒学机制。
Nature. 2014 Jan 23;505(7484):502-8. doi: 10.1038/nature12893. Epub 2013 Dec 18.
4
Improvement of antibody responses by HIV envelope DNA and protein co-immunization.HIV 包膜 DNA 和蛋白联合免疫可提高抗体应答。
Vaccine. 2014 Jan 16;32(4):507-13. doi: 10.1016/j.vaccine.2013.11.022. Epub 2013 Nov 23.
5
Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model.选定的 HIV-1 Env 三聚体制剂在兔疫苗接种模型中具有很强的免疫原性。
PLoS One. 2013 Sep 2;8(9):e74552. doi: 10.1371/journal.pone.0074552. eCollection 2013.
6
A twin-cysteine motif in the V2 region of gp120 is associated with SIV envelope trimer stabilization.V2 区的 gp120 中的双半胱氨酸基序与 SIV 包膜三聚体的稳定有关。
PLoS One. 2013 Jul 23;8(7):e69406. doi: 10.1371/journal.pone.0069406. Print 2013.
7
Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes.鉴定出一种 HIV-1 亚型 A 包膜,该包膜具有广泛的抗原性和中和敏感性,并能诱导针对三个不同表位的抗体。
J Virol. 2013 May;87(10):5372-83. doi: 10.1128/JVI.02827-12. Epub 2013 Mar 6.
8
Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design.基于HIV-1抗体的疫苗设计中的抗原性和免疫原性。
J AIDS Clin Res. 2012;S8:3. doi: 10.4172/2155-6113. Epub 2012 Mar 22.
9
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120.HIV-1 包膜三聚体比单体 gp120 引发更强的中和抗体反应。
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12111-6. doi: 10.1073/pnas.1204533109. Epub 2012 Jul 5.
10
Eliciting broad neutralizing antibody to HIV-1: envelopes of different lentivirus cross immunization by prime-boost vaccination.诱导广谱中和抗体对抗 HIV-1:通过初免-加强免疫接种用不同慢病毒包膜交叉免疫。
Vaccine. 2012 Aug 3;30(36):5316-23. doi: 10.1016/j.vaccine.2012.06.053. Epub 2012 Jun 27.